We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PLXS posted Q1 FY26 adjusted EPS of $1.78, beating estimates and improving from the prior-year quarter.
Plexus reported revenues of $1.07B, up 9.6% Y/Y, driven by strong growth in the Americas, EMEA and Healthcare.
PLXS logged 22 program wins worth $283M in annualized revenues.
Plexus Corp (PLXS - Free Report) reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of $1.78 compared with the year-ago quarter’s $1.73. The figure beat the Zacks Consensus Estimate of $1.77 per share. Management expected non-GAAP EPS to be in the band of $1.66-$1.81.
Revenues of $1.07 billion were up nearly 9.6% year over year but marginally missed the Zacks Consensus Estimate of $1.071 billion. Management expected revenues to be between $1.05 billion and $1.09 billion.
In the reported quarter, revenues from the Americas increased 25.9% to $345 million. Revenues from EMEA and Asia-Pacific increased 16.8% and 0.8%, respectively.
In the fiscal first quarter, Plexus announced 22 manufacturing program wins, which are estimated to contribute $283 million in annualized revenues once fully ramped into production.
Management highlighted that program wins, share gains and strengthening market demand position it for meeting/exceeding the high end of 9% to 12% revenue growth target for fiscal 2026.
Revenues from Aerospace/Defense were up 11.3% year over year and 3% quarter over quarter to $178 million. This segment contributed 17% to total revenues. Management guided for mid-single-digit sequential revenue growth for this sector. For the fiscal second quarter, PLXS expects growth (up mid-single digits) from program ramps and improving demand.
Healthcare/Life Sciences’ revenues were up 24.6% year over year and 10% quarter over quarter to $466 million. This contributed 43% to total revenues. PLXS expected the Healthcare Life Sciences sector’s revenues to grow in high single to low double digits sequentially. Management anticipates the current quarter revenues (flat to up low-single digits sequentially) to gain from strength in therapeutics.
Industrial sector’s revenues were down 3.6% year over year and 8% sequentially to $426 million. This segment contributed 40% to total revenues. PLXS expected the segment to register a high single-digit sequential revenue decrease in the fiscal first quarter. Management anticipates current-quarter revenues (up high-single to low-double digits sequentially) to be driven by market strength and program ramps in semicap and improving industrial equipment demand.
Our estimates for revenues from the Industrial, Healthcare/Life Sciences and Aerospace/Defense were $426.5 million, $462.2 million and $182.2 million, respectively.
The company’s top 10 customers accounted for 52% of net revenues in the fiscal first quarter.
Plexus’ Operating Details
Gross profit on a GAAP basis increased 5.4% year over year to $106.2 million. Gross margin was 9.9%, down from 10.3% reported in the year-ago quarter.
Selling and administrative expenses increased 5.1% from the year-ago quarter’s actuals to $51.7 million.
Adjusted operating margin contracted 20 basis points to 5.8%.
PLXS’ Cash Flow & Balance Sheet Position
As of Jan. 3, 2026, Plexus had cash & cash equivalents worth $248.8 million compared with $306.5 million as of Sept. 27, 2025.
PLXS had long-term debt and finance lease obligations, net of the current portion of $91.1 million as of Jan. 3, 2026, compared with $91.9 million as of Sept 27, 2025.
For the quarter under review, cash flows used in operations were $15.4 million. Plexus reported a negative free cash flow of $50.6 million after incurring capital expenditures of $35.2 million.
The company repurchased $22.4 million worth of shares at an average price of $146.36 per share under its repurchase program. Out of the $100 million authorization, $62.6 million remains available.
Plexus’ Q2 Outlook
For the second-quarter fiscal 2026, revenues are anticipated to be between $1.11 billion and $1.15 billion.
Non-GAAP operating margin is expected to be between 5.6% and 6%. Non-GAAP EPS is expected to be in the band of $1.80-$1.95.
Jabil Inc (JBL - Free Report) reported strong first-quarter fiscal 2026 results, with both bottom and top lines surpassing the Zacks Consensus Estimate. The company reported a top-line expansion year over year, owing to healthy traction in the data center infrastructure, capital equipment and healthcare end-markets.
Net sales during the quarter increased to $8.3 billion, up from $6.99 billion in the year-ago quarter. The top line beat the consensus estimate of $8.07 billion. Solid demand in the Intelligent Infrastructure segment boosted the top line. The Intelligent Infrastructure contributed 46% of total revenues, up 54% year over year. Healthy demand in the Capital Equipment, AI-related Cloud and Data Center Infrastructure verticals supported net sales.
Over the past year, shares of JBL have gained 49.7%.
Sanmina Corporation. (SANM - Free Report) reported first-quarter fiscal 2026 earnings per share of $2.38 compared with $1.44 year over year. Revenues of $3.19 billion beat the Zacks Consensus Estimate by 2.9%. The top line rose 59% year over year. SANM’s gross profit increased 44% year over year to $242.4 million.
Over the past year, shares of SANM have gained 84.3%.
Celestica (CLS - Free Report) reported healthy year-over-year revenues backed by robust expansion in the Connectivity & Cloud Solutions ("CCS") segment. Management’s emphasis on innovation, product diversification and AI advancements was a key growth driver. Solid growth in free cash flow was a tailwind.
Non-GAAP net earnings increased to $218.8 million or $1.89 per share from $130.2 million or $1.11 in the year-ago quarter. The bottom line beat the Zacks Consensus Estimate by 15 cents. Quarterly revenues were $3.65 billion, up 44% year over year, led by healthy demand in the CCS segment. The top line exceeded management’s guidance of $3.325 billion to $3.575 billion.
Over the past year, shares of CLS have gained 243.5%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Plexus' Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
Key Takeaways
Plexus Corp (PLXS - Free Report) reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of $1.78 compared with the year-ago quarter’s $1.73. The figure beat the Zacks Consensus Estimate of $1.77 per share. Management expected non-GAAP EPS to be in the band of $1.66-$1.81.
Revenues of $1.07 billion were up nearly 9.6% year over year but marginally missed the Zacks Consensus Estimate of $1.071 billion. Management expected revenues to be between $1.05 billion and $1.09 billion.
Plexus Corp. Price and EPS Surprise
Plexus Corp. price-eps-surprise | Plexus Corp. Quote
In the reported quarter, revenues from the Americas increased 25.9% to $345 million. Revenues from EMEA and Asia-Pacific increased 16.8% and 0.8%, respectively.
In the fiscal first quarter, Plexus announced 22 manufacturing program wins, which are estimated to contribute $283 million in annualized revenues once fully ramped into production.
Management highlighted that program wins, share gains and strengthening market demand position it for meeting/exceeding the high end of 9% to 12% revenue growth target for fiscal 2026.
Image Source: Zacks Investment Research
In the past year, shares have gained 26.1% compared with the Electronics- Manufacturing Services industry’s growth of 101.7%.
Looking at PLXS’ Market Sector Details
Revenues from Aerospace/Defense were up 11.3% year over year and 3% quarter over quarter to $178 million. This segment contributed 17% to total revenues. Management guided for mid-single-digit sequential revenue growth for this sector. For the fiscal second quarter, PLXS expects growth (up mid-single digits) from program ramps and improving demand.
Healthcare/Life Sciences’ revenues were up 24.6% year over year and 10% quarter over quarter to $466 million. This contributed 43% to total revenues. PLXS expected the Healthcare Life Sciences sector’s revenues to grow in high single to low double digits sequentially. Management anticipates the current quarter revenues (flat to up low-single digits sequentially) to gain from strength in therapeutics.
Industrial sector’s revenues were down 3.6% year over year and 8% sequentially to $426 million. This segment contributed 40% to total revenues. PLXS expected the segment to register a high single-digit sequential revenue decrease in the fiscal first quarter. Management anticipates current-quarter revenues (up high-single to low-double digits sequentially) to be driven by market strength and program ramps in semicap and improving industrial equipment demand.
Our estimates for revenues from the Industrial, Healthcare/Life Sciences and Aerospace/Defense were $426.5 million, $462.2 million and $182.2 million, respectively.
The company’s top 10 customers accounted for 52% of net revenues in the fiscal first quarter.
Plexus’ Operating Details
Gross profit on a GAAP basis increased 5.4% year over year to $106.2 million. Gross margin was 9.9%, down from 10.3% reported in the year-ago quarter.
Selling and administrative expenses increased 5.1% from the year-ago quarter’s actuals to $51.7 million.
Adjusted operating margin contracted 20 basis points to 5.8%.
PLXS’ Cash Flow & Balance Sheet Position
As of Jan. 3, 2026, Plexus had cash & cash equivalents worth $248.8 million compared with $306.5 million as of Sept. 27, 2025.
PLXS had long-term debt and finance lease obligations, net of the current portion of $91.1 million as of Jan. 3, 2026, compared with $91.9 million as of Sept 27, 2025.
For the quarter under review, cash flows used in operations were $15.4 million. Plexus reported a negative free cash flow of $50.6 million after incurring capital expenditures of $35.2 million.
The company repurchased $22.4 million worth of shares at an average price of $146.36 per share under its repurchase program. Out of the $100 million authorization, $62.6 million remains available.
Plexus’ Q2 Outlook
For the second-quarter fiscal 2026, revenues are anticipated to be between $1.11 billion and $1.15 billion.
Non-GAAP operating margin is expected to be between 5.6% and 6%. Non-GAAP EPS is expected to be in the band of $1.80-$1.95.
Zacks Rank of PLXS
Plexus currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Recent Performance of Peers
Jabil Inc (JBL - Free Report) reported strong first-quarter fiscal 2026 results, with both bottom and top lines surpassing the Zacks Consensus Estimate. The company reported a top-line expansion year over year, owing to healthy traction in the data center infrastructure, capital equipment and healthcare end-markets.
Net sales during the quarter increased to $8.3 billion, up from $6.99 billion in the year-ago quarter. The top line beat the consensus estimate of $8.07 billion. Solid demand in the Intelligent Infrastructure segment boosted the top line. The Intelligent Infrastructure contributed 46% of total revenues, up 54% year over year. Healthy demand in the Capital Equipment, AI-related Cloud and Data Center Infrastructure verticals supported net sales.
Over the past year, shares of JBL have gained 49.7%.
Sanmina Corporation. (SANM - Free Report) reported first-quarter fiscal 2026 earnings per share of $2.38 compared with $1.44 year over year. Revenues of $3.19 billion beat the Zacks Consensus Estimate by 2.9%. The top line rose 59% year over year. SANM’s gross profit increased 44% year over year to $242.4 million.
Over the past year, shares of SANM have gained 84.3%.
Celestica (CLS - Free Report) reported healthy year-over-year revenues backed by robust expansion in the Connectivity & Cloud Solutions ("CCS") segment. Management’s emphasis on innovation, product diversification and AI advancements was a key growth driver. Solid growth in free cash flow was a tailwind.
Non-GAAP net earnings increased to $218.8 million or $1.89 per share from $130.2 million or $1.11 in the year-ago quarter. The bottom line beat the Zacks Consensus Estimate by 15 cents. Quarterly revenues were $3.65 billion, up 44% year over year, led by healthy demand in the CCS segment. The top line exceeded management’s guidance of $3.325 billion to $3.575 billion.
Over the past year, shares of CLS have gained 243.5%.